This study demonstrates elevated G0S2 expression in HCC patients and its role in inhibiting CD8+T cell function by promoting PD-L1 expression, potentially leading to resistance to PD-1 inhibitors. The gene discussed is G0S2; the disease is hepatocellular carcinoma.